LB101

· Centessa Pharmaceuticals (UK) Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LB101, covering 2025-09-25 to 2025-09-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Preliminary Activity of LB101 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]

See pricing